Skip to main content
Signal8

Czibere Akos

SEC insider (Form 3/4/5 filer). CIK 0002049427. Chief Medical Officer at Aktis Oncology, Inc. (AKTS). 7 reported Form 4/5 transactions since Sep 2024; latest on Sep 23, 2026. Located in BOSTON, MA.

Companies Czibere Akos has filed insider reports for

  • Aktis Oncology, Inc. (AKTS): Officer, Chief Medical Officer
Czibere Akos profile photo

Czibere Akos

CIK: 0002049427

Transaction Breakdown

Open Market Buys (P)0 (0.0%)

High conviction signal

Open Market Sales (S)5 (71.4%)

Position reduction

Option Exercises (M)2 (28.6%)

Derivative conversions

Awards (A)0 (0.0%)

Compensation grants

Other (G, F, J, C, D, …)0 (0.0%)

Gifts, tax withholding, conversions, dispositions to the issuer and other codes

Companies & Roles (1)

Aktis Oncology, Inc. logo
AKTS

Aktis Oncology, Inc.

Officer

Discretionary Trading P&L

Holdings

Transaction History (7 total)

  • Aktis Oncology, Inc. logo
    AKTS

    Aktis Oncology, Inc.

    Sep 23, 2026
    Exercise
    Direct
    12.5K shares at avg. $4.95$62K
  • Aktis Oncology, Inc. logo
    AKTS

    Aktis Oncology, Inc.

    Sep 23, 2026
    Sale
    Direct
    5.1K shares at avg. $20.19$103K
  • Aktis Oncology, Inc. logo
    AKTS

    Aktis Oncology, Inc.

    Sep 23, 2026
    Sale
    Direct
    7.4K shares at avg. $21.03$156K
  • Aktis Oncology, Inc. logo
    AKTS

    Aktis Oncology, Inc.

    Jul 8, 2026
    Exercise
    Direct
    50K shares at avg. $4.95$248K
  • Aktis Oncology, Inc. logo
    AKTS

    Aktis Oncology, Inc.

    Jul 8, 2026
    Sale
    Direct
    4.4K shares at avg. $28.71$125K
  • Aktis Oncology, Inc. logo
    AKTS

    Aktis Oncology, Inc.

    Jul 8, 2026
    Sale
    Direct
    14.8K shares at avg. $27.13$401K
  • Aktis Oncology, Inc. logo
    AKTS

    Aktis Oncology, Inc.

    Jul 8, 2026
    Sale
    Direct
    30.8K shares at avg. $27.95$862K

1-7 of 7